Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 12.94 million. The enterprise value is 4.47 million.
| Market Cap | 12.94M |
| Enterprise Value | 4.47M |
Important Dates
The next estimated earnings date is Monday, June 22, 2026.
| Earnings Date | Jun 22, 2026 |
| Ex-Dividend Date | Feb 27, 2026 |
Share Statistics
Pharma-Bio Serv has 22.90 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 22.90M |
| Shares Outstanding | 22.90M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 54.99% |
| Owned by Institutions (%) | 1.49% |
| Float | 8.37M |
Valuation Ratios
The trailing PE ratio is 210.42 and the forward PE ratio is 5.65.
| PE Ratio | 210.42 |
| Forward PE | 5.65 |
| PS Ratio | 1.42 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 72.64 |
| EV / Sales | 0.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.80
| Current Ratio | 10.80 |
| Quick Ratio | 10.71 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.54% and return on invested capital (ROIC) is -166.88%.
| Return on Equity (ROE) | 0.54% |
| Return on Assets (ROA) | -1.95% |
| Return on Invested Capital (ROIC) | -166.88% |
| Return on Capital Employed (ROCE) | -3.80% |
| Weighted Average Cost of Capital (WACC) | 7.98% |
| Revenue Per Employee | 165,648 |
| Profits Per Employee | 1,118 |
| Employee Count | 55 |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharma-Bio Serv has paid 9,574 in taxes.
| Income Tax | 9,574 |
| Effective Tax Rate | 13.47% |
Stock Price Statistics
The stock price has increased by +15.31% in the last 52 weeks. The beta is 0.68, so Pharma-Bio Serv's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +15.31% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 53.99 |
| Average Volume (20 Days) | 3,083 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.11 million and earned 61,494 in profits. Earnings per share was 0.00.
| Revenue | 9.11M |
| Gross Profit | 2.95M |
| Operating Income | -397,008 |
| Pretax Income | 71,068 |
| Net Income | 61,494 |
| EBITDA | -337,011 |
| EBIT | -397,008 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 8.47 million in cash and n/a in debt, with a net cash position of 8.47 million or 0.37 per share.
| Cash & Cash Equivalents | 8.47M |
| Total Debt | n/a |
| Net Cash | 8.47M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 10.45M |
| Book Value Per Share | 0.46 |
| Working Capital | 10.24M |
Cash Flow
In the last 12 months, operating cash flow was -239,260 and capital expenditures -7,118, giving a free cash flow of -246,378.
| Operating Cash Flow | -239,260 |
| Capital Expenditures | -7,118 |
| Depreciation & Amortization | 65,223 |
| Net Borrowing | n/a |
| Free Cash Flow | -246,378 |
| FCF Per Share | -0.01 |
Margins
Gross margin is 32.35%, with operating and profit margins of -4.36% and 0.67%.
| Gross Margin | 32.35% |
| Operating Margin | -4.36% |
| Pretax Margin | 0.78% |
| Profit Margin | 0.67% |
| EBITDA Margin | -3.70% |
| EBIT Margin | -4.36% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 13.27%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 13.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 2,793.16% |
| Buyback Yield | 0.13% |
| Shareholder Yield | 13.41% |
| Earnings Yield | 0.48% |
| FCF Yield | -1.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 10.22 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.22 |
| Piotroski F-Score | 4 |